Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects
Clinical trial NCT07134478 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07134478
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-28
- Primary completion
- 2024-12-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.